U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
182011182011Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced CancerCompletedNo Results AvailableTumors|Neoplasm MetastasisDrug: PTK787/ZK 222584 (vatalanib)https://ClinicalTrials.gov/show/NCT00171587
182012182012Antiproteinuric Effect of Valsartan and LisinoprilCompletedNo Results AvailableHypertension|Diabetic NephropathyDrug: Valsartan|Drug: Valsartan plus HCTZ|Drug: Lisinoprilhttps://ClinicalTrials.gov/show/NCT00171574
182013182013Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.CompletedNo Results AvailableHypertensionDrug: valsartan/hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT00171561
182014182014Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome PatientsCompletedNo Results AvailableMetabolic Syndromehttps://ClinicalTrials.gov/show/NCT00171548
182015182015Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe HypertensionCompletedNo Results AvailableHypertensionDrug: valsartan/amlodipinehttps://ClinicalTrials.gov/show/NCT00171535
182016182016Preference of Tegaserod vs. PEG 3350 in Patients With ConstipationCompletedNo Results AvailableConstipationDrug: Tegaserod and Polyethylene Glycol 3350https://ClinicalTrials.gov/show/NCT00171522
182017182017Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant RecipientsCompletedNo Results AvailableLiver TransplantDrug: Cyclosporine microemulsionhttps://ClinicalTrials.gov/show/NCT00171509
182018182018Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation RecipientsCompletedNo Results AvailableKidney TransplantDrug: Cyclosporine microemulsion|Drug: Tacrolimushttps://ClinicalTrials.gov/show/NCT00171496
182019182019Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNo Results AvailableGastroesophageal Reflux Disease (GERD)Drug: Tegaserodhttps://ClinicalTrials.gov/show/NCT00171483
182020182020The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.CompletedNo Results AvailableDyspepsiaDrug: Tegaserodhttps://ClinicalTrials.gov/show/NCT00171470
182021182021The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.CompletedNo Results AvailableHeartburn|DyspepsiaDrug: Tegaserodhttps://ClinicalTrials.gov/show/NCT00171457
182022182022Comparison of Two Treatment Strategies in Hypertensive PatientsCompletedNo Results AvailableHypertensionBehavioral: Medical educationhttps://ClinicalTrials.gov/show/NCT00171444
182023182023The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)TerminatedNo Results AvailableConstipation Predominant|Irritable Bowel Syndrome (IBS-C)Drug: Tegaserodhttps://ClinicalTrials.gov/show/NCT00171431
182024182024Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNo Results AvailableGastroesophageal Reflux Disease (GERD)Drug: Tegaserodhttps://ClinicalTrials.gov/show/NCT00171418
182025182025A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mgCompletedNo Results AvailableHypertensionDrug: aliskirenhttps://ClinicalTrials.gov/show/NCT00171405
182026182026Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving TacrolimusCompletedNo Results AvailablePrevention of Acute Rejection After Kidney TransplantationDrug: Enteric-coated mycophenolate sodiumhttps://ClinicalTrials.gov/show/NCT00171392
182027182027Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal TransplantCompletedNo Results AvailablePrevention of Acute Rejection After Kidney TransplantationDrug: Enteric-Coated Mycophenolate Sodiumhttps://ClinicalTrials.gov/show/NCT00171379
182028182028A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.CompletedNo Results AvailableHypertensionDrug: amlodipine/benazeprilhttps://ClinicalTrials.gov/show/NCT00171366
182029182029A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood PressureCompletedNo Results AvailableHypertensionDrug: valsartanhttps://ClinicalTrials.gov/show/NCT00171353
182030182030Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.CompletedHas ResultsBone Loss|Breast CancerDrug: Zoledronic acid|Drug: Letrozolehttps://ClinicalTrials.gov/show/NCT00171340
182031182031Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial DysfunctionCompletedNo Results AvailableHypertension|DyslipidemiaDrug: valsartan, fluvastatinhttps://ClinicalTrials.gov/show/NCT00171327
182032182032The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast CancerCompletedHas ResultsBreast CancerDrug: Zoledronic acid|Drug: Letrozolehttps://ClinicalTrials.gov/show/NCT00171314
182033182033Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)CompletedHas ResultsBeta-thalassemia Major|Hemosiderosis|Iron Overload|Rare AnemiaDrug: Deferasiroxhttps://ClinicalTrials.gov/show/NCT00171301
182034182034Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin AloneCompletedNo Results AvailableDyslipidemiaDrug: fluvastatin, ezetimibehttps://ClinicalTrials.gov/show/NCT00171288
182035182035Fluvastatin in the Therapy of Acute Coronary SyndromeCompletedNo Results AvailableCoronary Disease|Myocardial InfarctionDrug: Fluvastatinhttps://ClinicalTrials.gov/show/NCT00171275
182036182036Trial to Evaluate the Efficacy of Fluvastatin on Certain MarkersCompletedNo Results AvailableDyslipidemiaDrug: Fluvastatinhttps://ClinicalTrials.gov/show/NCT00171262
182037182037An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + LeukemiaCompletedNo Results AvailablePhiladelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid LeukemiaDrug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00171249
182038182038Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial HypercholesterolemiaCompletedNo Results AvailableHeterozygous Familial Hypercholesterolemia|Mixed DyslipidemiaDrug: Fluvastatinhttps://ClinicalTrials.gov/show/NCT00171236
182039182039An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + LeukemiaCompletedNo Results AvailablePhiladelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid LeukemiaDrug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00171223
182040182040An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron OverloadCompletedHas ResultsTransfusional Iron Overload in β-thalassemiaDrug: Deferasiroxhttps://ClinicalTrials.gov/show/NCT00171210

* Görseller ve İçerik tekif hakkına sahip olabilir